Background & aims: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder associated with significant disease burden. This American Gastroenterological Association Guideline is intended to support practitioners in decisions about the use of medications for the pharmacological man...
Irritable bowel syndrome (IBS) is a common disorder of gut–brain interaction associated with significant disease burden. This American Gastroenterological Association guideline is intended to support practitioners in decisions about the use of medications for the pharmacological management of IBS-C and...
Mack, David R;
Benchimol, Eric I;
Critch, Jeff;
de Bruyn, Jennifer;
Tse, Frances;
Moayyedi, Paul;
Church, Peter;
Deslandres, Colette;
El-Matary, Wael;
Huynh, Hien;
Jantchou, Prévost;
Lawrence, Sally;
Otley, Anthony;
Sherlock, Mary;
Walters, Thomas;
Kappelman, Michael D;
Sadowski, Dan;
Marshall, John K;
Griffiths, Anne.
We aim to provide guidance for medical treatment of luminal Crohn’s disease in children. We performed a systematic search of publication databases to identify studies of medical management of pediatric Crohn’s disease. Quality of evidence and strength of recommendations were rated according to the G...
This article has an accompanying continuing medical education activity on page e17. Learning Objective: Upon completion of this test, successful learners will be able to: (1) learn first-line treatment for the induction of remission in microscopic colitis; (2) identify the expected clinical benefi ts and...
Bressler, B;
Marshall, J. K;
Bernstein, C. N;
Bitton, A;
Jones, J;
Leontiadis, G. I;
Panaccione, R;
Steinhart, A. H;
Tse, F;
Feagan, B.
BACKGROUND & AIMS:: The medical management of ulcerative colitis (UC) has improved through the development of new therapies and novel approaches that optimize existing drugs. Previous Canadian consensus guidelines addressed the management of severe UC in the hospitalized patient. We now present consensu...
Factor de Necrosis Tumoral alfa,
Mercaptopurina,
Azatioprina,
Metotrexato,
Enfermedad de Crohn,
Gastroenterología,
Mercaptopurina/uso terapéutico,
Metotrexato/uso terapéutico,
Inducción de Remisión,
Enfermedad de Crohn/tratamiento farmacológico,
Factor de Necrosis Tumoral alfa/antagonistas & inhibidores